A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee
2008

Efficacy and Safety of 5-Loxin® for Osteoarthritis of the Knee

Sample size: 75 publication 10 minutes Evidence: high

Author Information

Author(s): Sengupta Krishanu, Alluri Krishnaraju V, Satish Andey Rama, Mishra Simanchala, Golakoti Trimurtulu, Sarma Kadainti VS, Dey Dipak, Raychaudhuri Siba P

Primary Institution: Alluri Sitarama Raju Academy of Medical Sciences (ASRAM)

Hypothesis

Does 5-Loxin® improve pain and physical function in patients with osteoarthritis of the knee?

Conclusion

5-Loxin® significantly reduces pain and improves physical functioning in osteoarthritis patients and is safe for human consumption.

Supporting Evidence

  • Both doses of 5-Loxin® showed significant improvements in pain and physical function scores.
  • Improvements were noted as early as 7 days after starting treatment.
  • 5-Loxin® reduced levels of the cartilage degrading enzyme MMP-3 in synovial fluid.
  • The safety parameters remained unchanged in the treatment groups compared to placebo.

Takeaway

5-Loxin® is a natural supplement that helps people with knee pain feel better and move easier.

Methodology

A 90-day, double-blind, randomized, placebo-controlled study with 75 osteoarthritis patients receiving either 100 mg or 250 mg of 5-Loxin® or a placebo.

Potential Biases

Potential bias in patient selection and reporting of outcomes.

Limitations

The study was conducted at a single center and had a relatively small sample size.

Participant Demographics

Patients aged 40 years or older with a diagnosis of osteoarthritis.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/ar2461

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication